Buprenorphine And Naloxone 67877-0606
Product NDC
67877-0606- Manufacturer
- Ascend Laboratories, Llc
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- July 3, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA214930
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
| Naloxone Hydrochloride | 2 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Packaging Options(3)
30 TABLET in 1 BOTTLE (67877-606-30)
3 BLISTER PACK in 1 CARTON (67877-606-84) / 10 TABLET in 1 BLISTER PACK
90 TABLET in 1 BOTTLE (67877-606-90)